Skip to main content
logo
ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · Real-Time Price · USD
73.75
+1.51 (2.09%)
At close: Oct 22, 2026, 4:00 PM EDT
73.38
-0.38 (-0.51%)
Pre-market: Oct 23, 2026, 5:20 AM EDT

ANI Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
978.38883.37614.38486.82316.39216.14
Revenue Growth
30.90%43.78%26.20%53.87%46.38%3.67%
Gross Profit
590.98542.06377.77305.3177.6115.53
Operating Income
123.683.3333.9249.53-25.73-28.17
Net Income
99.670.22-20.1515.48-49.52-42.79
Earnings Per Share
4.543.32-1.040.85-3.05-3.40
EPS Growth
------

Revenue by Segment
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Generics and Other
412.06399.43320.03289.31235.24
Rare Disease and Brands
566.32483.93294.34197.581.15
Total
978.38883.37614.38486.82316.39

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
376.96294.72151.17221.1248.23100.3
Total Debt
626.03628.28624.09285.67287.9287.37
Net Cash (Debt)
-249.07-333.57-472.92-64.55-239.67-187.07
Net Cash Growth
------
Net Cash Per Share
-11.30-15.71-24.48-3.55-14.74-14.85

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
189.47185.2364.02118.96-31.23.32
Capital Expenditures
-16.48-13.84-16.24-8.87-8.88-2.56
Free Cash Flow
172.99171.3947.78110.09-40.080.77
Free Cash Flow Growth
37.90%258.70%-56.60%---91.62%

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
60.40%61.36%61.49%62.71%56.13%53.45%
Operating Margin
12.63%9.43%5.52%10.17%-8.13%-13.03%
Pretax Margin
14.57%10.84%-3.62%4.08%-19.81%-25.94%
Profit Margin
10.18%7.95%-3.28%3.18%-15.65%-19.80%
FCF Margin
17.68%19.40%7.78%22.61%-12.67%0.35%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
16.2523.50-68.00--
Forward PE
8.0510.0310.7214.0414.7912.86
P/FCF Ratio
9.149.6322.599.56-1008.43
PS Ratio
1.621.871.762.162.073.57